These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mineralocorticoid-stimulating activity of adipose tissue. Lamounier-Zepter V; Ehrhart-Bornstein M; Bornstein SR Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):567-75. PubMed ID: 16311217 [TBL] [Abstract][Full Text] [Related]
3. Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity. Roberge C; Carpentier AC; Langlois MF; Baillargeon JP; Ardilouze JL; Maheux P; Gallo-Payet N Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1465-78. PubMed ID: 17911338 [TBL] [Abstract][Full Text] [Related]
5. Role of adipose tissue for cardiovascular-renal regulation in health and disease. Engeli S; Sharma AM Horm Metab Res; 2000; 32(11-12):485-99. PubMed ID: 11246814 [TBL] [Abstract][Full Text] [Related]
6. Role of renin-angiotensin system in adipose tissue dysfunction. Iwai M; Horiuchi M Hypertens Res; 2009 Jun; 32(6):425-7. PubMed ID: 19407825 [TBL] [Abstract][Full Text] [Related]
7. The association of aldosterone with obesity-related hypertension and the metabolic syndrome. Vogt B; Bochud M; Burnier M Semin Nephrol; 2007 Sep; 27(5):529-37. PubMed ID: 17868790 [TBL] [Abstract][Full Text] [Related]
8. The development and endocrine functions of adipose tissue. Poulos SP; Hausman DB; Hausman GJ Mol Cell Endocrinol; 2010 Jul; 323(1):20-34. PubMed ID: 20025936 [TBL] [Abstract][Full Text] [Related]
9. The autocrine and paracrine roles of adipokines. Karastergiou K; Mohamed-Ali V Mol Cell Endocrinol; 2010 Apr; 318(1-2):69-78. PubMed ID: 19948207 [TBL] [Abstract][Full Text] [Related]
11. From big fat cells to high blood pressure: a pathway to obesity-associated hypertension. Pausova Z Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):173-8. PubMed ID: 16481885 [TBL] [Abstract][Full Text] [Related]
12. Adrenocortical dysfunction in obesity and the metabolic syndrome. Krug AW; Ehrhart-Bornstein M Horm Metab Res; 2008 Aug; 40(8):515-7. PubMed ID: 18446685 [TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor activation in obesity hypertension. Nagase M; Fujita T Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418 [TBL] [Abstract][Full Text] [Related]
14. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. Sarzani R; Salvi F; Dessì-Fulgheri P; Rappelli A J Hypertens; 2008 May; 26(5):831-43. PubMed ID: 18398321 [TBL] [Abstract][Full Text] [Related]
16. Inflamed adipose tissue, insulin resistance and vascular injury. Andersson CX; Gustafson B; Hammarstedt A; Hedjazifar S; Smith U Diabetes Metab Res Rev; 2008; 24(8):595-603. PubMed ID: 18756581 [TBL] [Abstract][Full Text] [Related]
17. Adipokines as novel modulators of lipid metabolism. Lago F; Gómez R; Gómez-Reino JJ; Dieguez C; Gualillo O Trends Biochem Sci; 2009 Oct; 34(10):500-10. PubMed ID: 19729309 [TBL] [Abstract][Full Text] [Related]
18. Overview of adipose tissue and its role in obesity and metabolic disorders. Frühbeck G Methods Mol Biol; 2008; 456():1-22. PubMed ID: 18516549 [TBL] [Abstract][Full Text] [Related]
19. New mechanisms to control aldosterone synthesis. Willenberg HS; Schinner S; Ansurudeen I Horm Metab Res; 2008 Jul; 40(7):435-41. PubMed ID: 18493881 [TBL] [Abstract][Full Text] [Related]
20. Essential hypertension: is there a role for inflammatory mechanisms? Androulakis ES; Tousoulis D; Papageorgiou N; Tsioufis C; Kallikazaros I; Stefanadis C Cardiol Rev; 2009; 17(5):216-21. PubMed ID: 19690472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]